Shenzhen medical technology company Lead Medical raised ￥30 million in a series A round funding by Magsun Capital. The investment will mainly be used to expand laboratory, offline clinics, and recruit employees.
Established in 2013, Lead Medical is committed to the prevention and management of chronic diseases and sub-health via the sequence analysis of intestinal metagenome, the deep development of targeting remodulation of intestinal micro-ecosystem, and the optimization of bio-medical big data analysis and the structural graph of intestinal flora.
South Africa Today
Read more at VolaNews
